Business Services Industry
AstraZeneca Calls Off Launch of Bronchitis Treatment.
Knight Ridder/Tribune Business News, June, 2001
By Cliff Feltham, Daily Mail, London Knight Ridder/Tribune Business News
Jun. 28--Drug giant AstraZeneca halted plans to launch a treatment to fight bronchitis, after spending millions testing over 4,000 patients in 24 countries.
The Anglo Swedish group declined to say how much it had spent on the drug, although industry experts say it can cost up to UKpound 350 million to bring a new product to the market.
AstraZeneca, where Tom McKillop is chief executive, said Viozan, a treatment for smokers" illnesses such as bronchitis and emphysema, failed to maintain benefits in late stage tests.
One analyst said: "It is just another piece of bad news for the sector. Viozan was never going to be huge, but it was one of the strings to the...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Design a commission plan that drives sales - Sales Commissions
